Abstract
Koruyucu sağlık hizmetlerinin önemi tekrar tekrar gündeme gelirken, sağlık profesyonelleri artık, artan geriatrik nüfusun sorunlarını, henüz ortaya çıkmadan, irdeleyerek çözümler aramaktadır. Geriatrik hastalarda ilaç-ilaç etkileşimi riski, etkileşme olasılığı daha düşük olan ilaç grupları seçilerek kısmen de olsa önlenebilmektedir. Geriatrik hastalarda ilaç seçimi, kısa sürede hiponatremiye neden olabilecek serotonin-norepinefrin geri alım inhibitörleri, seçici serotonin geri alım inhibitörIeri, diüretikler, proton pompa inhibitörleri ve non-steroidal anti-inflamatuvar ilaçlar gibi potansiyel medikasyonların kullanımında önemli olabilmektedir. Bu olgu sunumunda venlafaksin kullanımı sonrası hiponatremi gelişen bir geriatrik hasta sunulmuştur.
References
- Venlafaxine: more dangerous than most "selective" serotonergic antidepressants. Prescrire Int 2016; 25 (170): 96-9.
- Liamis G, Megapanou E, Elisaf M, Milionis H. Hyponatremia-Inducing Drugs. Front Horm Res 2019; 52: 167-77.
- Coupland C, Dhiman P, Morriss R, Arthur A, Barton G, Hippisley-Cox J. Antidepressant use and risk of adverse outcomes in older people: population-based cohort study. BMJ 2011; 2 (343): d4551.
- De Picker L, Van Den Eede F, Dumont G, Moorkens G, Sabbe BG. Antidepressants and the risk of hyponatremia: a class-by-class review of literature. Psychosomatics 2014; 55 (6): 536-47.
- Filippatos TD, Makri A, Elisaf MS. Hyponatremia in the elderly: challenges and solutions. Clin Interv Aging 2017; 14 (12): 1957-65.
Abstract
While the value of preventive healthcare services comes up repeatedly, the healthcare professionals are now trying to find solutions for the expanding geriatric population's problems before they occur. The risk of drug-drug interactions may get preventively reduced in older patients with the selection of co-medications that are less likely to interact. The choice of drugs for older patients is crucial when commencing with potential incriminated agents together, such as, serotonin and norepinephrine reuptake inhibitors, selective serotonin reuptake inhibitors, diuretics, proton pump inhibitors, nonsteroidal anti-inflammatory drugs, etc., which could interact with each other and cause hyponatremia in a short period of time. In this paper, a rare case of an older patient with venlafaxineinduced hyponatremia has been presented.
References
- Venlafaxine: more dangerous than most "selective" serotonergic antidepressants. Prescrire Int 2016; 25 (170): 96-9.
- Liamis G, Megapanou E, Elisaf M, Milionis H. Hyponatremia-Inducing Drugs. Front Horm Res 2019; 52: 167-77.
- Coupland C, Dhiman P, Morriss R, Arthur A, Barton G, Hippisley-Cox J. Antidepressant use and risk of adverse outcomes in older people: population-based cohort study. BMJ 2011; 2 (343): d4551.
- De Picker L, Van Den Eede F, Dumont G, Moorkens G, Sabbe BG. Antidepressants and the risk of hyponatremia: a class-by-class review of literature. Psychosomatics 2014; 55 (6): 536-47.
- Filippatos TD, Makri A, Elisaf MS. Hyponatremia in the elderly: challenges and solutions. Clin Interv Aging 2017; 14 (12): 1957-65.
Details
| Primary Language | English |
|---|---|
| Subjects | Health Care Administration |
| Journal Section | Case Reports |
| Authors | |
| Publication Date | April 19, 2021 |
| Submission Date | January 18, 2021 |
| Published in Issue | Year 2021Volume: 60 Suppl:1 (Geriatrics) |
